tiprankstipranks
Advertisement
Advertisement

IMNM Stock Latest News

Immunome announces first patient dosed in Phase 1 IM-3050 trial
The FlyImmunome announces first patient dosed in Phase 1 IM-3050 trial
15d ago
IMNM
FDA NDA Acceptance and Strong RINGSIDE Data Support Immunome Buy Rating and Unchanged $40 Price Target
PremiumRatings
FDA NDA Acceptance and Strong RINGSIDE Data Support Immunome Buy Rating and Unchanged $40 Price Target
27d ago
IMNM
Immunome’s NDA for varegacestat in desmoid tumors accepted by FDA
PremiumThe Fly
Immunome’s NDA for varegacestat in desmoid tumors accepted by FDA
27d ago
IMNM
Analyst Brian Cheng Initiates Buy on Immunome, Citing Differentiated Pipeline and Compelling Risk‑Reward Profile
PremiumRatings
Analyst Brian Cheng Initiates Buy on Immunome, Citing Differentiated Pipeline and Compelling Risk‑Reward Profile
1M ago
IMNM
Immunome’s New Radiopharma Trial Puts IMNM on Early Oncology Watchlists
PremiumCompany Announcements
Immunome’s New Radiopharma Trial Puts IMNM on Early Oncology Watchlists
2M ago
IMNM
Immunome shareholders reaffirm board, auditor and pay policies
PremiumCompany AnnouncementsImmunome shareholders reaffirm board, auditor and pay policies
2M ago
8K
IMNM
Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile
Premium
Ratings
Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile
2M ago
IMNM
Immunome announces first patient dosed in Phase 1 trial of IM-1617
Premium
The Fly
Immunome announces first patient dosed in Phase 1 trial of IM-1617
2M ago
IMNM
Immunome Reaffirmed at Buy as Varegacestat Data Underscore Competitive Edge; $40 Price Target Maintained
PremiumRatings
Immunome Reaffirmed at Buy as Varegacestat Data Underscore Competitive Edge; $40 Price Target Maintained
2M ago
IMNM
Immunome announces Ringside trial met primary, secondary endpoints
PremiumThe Fly
Immunome announces Ringside trial met primary, secondary endpoints
2M ago
IMNM
Immunome price target raised to $37 from $36 at Truist
PremiumThe Fly
Immunome price target raised to $37 from $36 at Truist
2M ago
IMNM
Immunome initiated with an Overweight at Barclays
PremiumThe Fly
Immunome initiated with an Overweight at Barclays
2M ago
IMNM
Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial
PremiumCompany AnnouncementsImmunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial
2M ago
IMNM
Immunome price target lowered to $33 from $37 at Leerink
Premium
The Fly
Immunome price target lowered to $33 from $37 at Leerink
3M ago
IMNM
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
Premium
Ratings
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
3M ago
IMNM
Analyst Reiterates Buy on Immunome, Maintains $40 Price Target on Varegacestat Progress and Pipeline Upside
PremiumRatings
Analyst Reiterates Buy on Immunome, Maintains $40 Price Target on Varegacestat Progress and Pipeline Upside
3M ago
IMNM
Immunome reports Q1 EPS (48c), consensus (54c)
PremiumThe Fly
Immunome reports Q1 EPS (48c), consensus (54c)
3M ago
IMNM
Immunome announces submission of NDA for varegacestat in desmoid tumors
PremiumThe Fly
Immunome announces submission of NDA for varegacestat in desmoid tumors
3M ago
IMNM
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
PremiumThe Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
4M ago
GILD
IMNM
Immunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
PremiumRatingsImmunome: Best-in-Class Varegacestat Data and Deep ADC Pipeline Support Buy Rating and Favorable Risk‑Reward
5M ago
IMNM
Immunome price target lowered to $30 from $32 at Lake Street
Premium
The Fly
Immunome price target lowered to $30 from $32 at Lake Street
5M ago
IMNM
Immunome price target raised to $36 from $33 at Craig-Hallum
Premium
The Fly
Immunome price target raised to $36 from $33 at Craig-Hallum
5M ago
IMNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >